Spectrophotometric Methods for the Determination of Ketoconazole in Pharmaceutical Dosage Forms
Purpose: To develop simple, sensitive and economical methods for the determination of (KZ) in both pure samples and pharmaceutical formulations.
Methods: The first method (A) was based on the oxidation of the studied drug by a known excess of cerium (IV) as an oxidizing agent and subsequent determination of unreacted oxidant by reacting it with indigo carmine (IN) dye. The second method (B) involved potassium permanganate as oxidant and methylene blue (MB) as dye. Spectrophotometry was used to determine the residual amount of the dyes
by measuring the absorbance of the two dyes at 610 and 660 nm, respectively. Comparison was made with the British Pharmacopoeia 1998 method.
Results: Linear calibration graphs were obtained at 4 - 30 and 5 - 35 ìg/ml for the two methods at 610 and 660 nm, respectively. The regression equation was Y = 0.01X + 0.133, (R2 = 0.996, RSD = 78 % and limit of detection (LOD) of ìg/ml for method A. For the second method (B), it was Y = 0.008X + 0.039, (R2 = 0.995), RSD = 0.95 % and LOD = 2.3 ìg/ml. The proposed methods were successfully applied to the determination of KZ in pharmaceutical formulations.
Conclusion: The results demonstrate that the methods are as accurate and reproducible as official methods.
Keywords: Ketoconazole, Spectrophotometry, Cerium, Permanganate, Indigo carmine, Methylene blue.
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.